| 1 |
Wang X, Gu Y, Zhang L, Ma J, Xia Y, Wang X. Long noncoding RNAs regulate intrauterine adhesion and cervical cancer development and progression. Semin Cell Dev Biol 2023:S1084-9521(23)00036-8. [PMID: 36841649 DOI: 10.1016/j.semcdb.2023.02.007] [Reference Citation Analysis]
|
| 2 |
Hashemi M, Mirdamadi MSA, Talebi Y, Khaniabad N, Banaei G, Daneii P, Gholami S, Ghorbani A, Tavakolpournegari A, Farsani ZM, Zarrabi A, Nabavi N, Zandieh MA, Rashidi M, Taheriazam A, Entezari M, Khan H. Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. Pharmacol Res 2023;187:106568. [PMID: 36423787 DOI: 10.1016/j.phrs.2022.106568] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 3 |
Lei F, Li P, Chen T, Wang Q, Wang C, Liu Y, Deng Y, Zhang Z, Xu M, Tian J, Ren W, Li C. Recent advances in curcumin-loaded biomimetic nanomedicines for targeted therapies. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104200] [Reference Citation Analysis]
|
| 4 |
Wang M, Zhu L, Yang X, Li J, Liu Y, Tang Y. Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer. Front Pharmacol 2023;14:1132158. [PMID: 36874015 DOI: 10.3389/fphar.2023.1132158] [Reference Citation Analysis]
|
| 5 |
Zhu Z, Jiang H, Xie J, Jin X, Li B, Liu J. Current evidence on circRNAs as potential theranostic markers for detecting chemoresistance in breast cancer: a systematic review and meta‑analysis. Sci Rep 2022;12:22016. [PMID: 36539545 DOI: 10.1038/s41598-022-26220-z] [Reference Citation Analysis]
|
| 6 |
Wang W, Liu W, Chen Q, Yuan Y, Wang P. Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy. Semin Cancer Biol 2022;87:84-97. [PMID: 36371028 DOI: 10.1016/j.semcancer.2022.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Zhou M, Liu L, Wang J, Liu W. The role of long noncoding RNAs in therapeutic resistance in cervical cancer. Front Cell Dev Biol 2022;10. [DOI: 10.3389/fcell.2022.1060909] [Reference Citation Analysis]
|
| 8 |
Bravo-Vázquez LA, Frías-Reid N, Ramos-Delgado AG, Osorio-Pérez SM, Zlotnik-Chávez HR, Pathak S, Banerjee A, Bandyopadhyay A, Duttaroy AK, Paul S. MicroRNAs and long non-coding RNAs in pancreatic cancer: From epigenetics to potential clinical applications. Transl Oncol 2022;27:101579. [PMID: 36332600 DOI: 10.1016/j.tranon.2022.101579] [Reference Citation Analysis]
|
| 9 |
Chen W, Chen F, Gong M, Jin Z, Shu L, Wang Z, Wang J. Comprehensive analysis of lncRNA-mediated ceRNA networkfor hepatocellular carcinoma. Front Oncol 2022;12:1042928. [DOI: 10.3389/fonc.2022.1042928] [Reference Citation Analysis]
|
| 10 |
Cheng Y, Wu X, Xia Y, Liu W, Wang P. The role of lncRNAs in regulation of DKD and diabetes-related cancer. Front Oncol 2022;12:1035487. [DOI: 10.3389/fonc.2022.1035487] [Reference Citation Analysis]
|
| 11 |
Yu Y, Xia LK, Di Y, Nie QZ, Chen XL. Mechanism of piR-1245/PIWI-like protein-2 regulating Janus kinase-2/signal transducer and activator of transcription-3/vascular endothelial growth factor signaling pathway in retinal neovascularization. Neural Regen Res 2023;18:1132-8. [PMID: 36255003 DOI: 10.4103/1673-5374.355819] [Reference Citation Analysis]
|
| 12 |
Song Z, Wang X, Chen F, Chen Q, Liu W, Yang X, Zhu X, Liu X, Wang P. LncRNA MALAT1 regulates METTL3-mediated PD-L1 expression and immune infiltrates in pancreatic cancer. Front Oncol 2022;12:1004212. [DOI: 10.3389/fonc.2022.1004212] [Reference Citation Analysis]
|
| 13 |
Chen L, Wang J, Liu Q. Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer. Front Cell Dev Biol 2022;10:999174. [DOI: 10.3389/fcell.2022.999174] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 14 |
Li R, Chen Z, Zhou Y, Maimaitirexiati G, Yan Q, Li Y, Maimaitiyimin A, Zhou C, Ren J, Liu C, Mainike A, Zhou P, Ding L. LncRNA SCAMP1 disrupts the balance between miR-26a-5p and ZEB2 to promote osteosarcoma cell viability and invasion. Front Oncol 2022;12:967000. [DOI: 10.3389/fonc.2022.967000] [Reference Citation Analysis]
|
| 15 |
Yao W, Li S, Liu R, Jiang M, Gao L, Lu Y, Liang X, Zhang H. Long non-coding RNA PVT1: A promising chemotherapy and radiotherapy sensitizer. Front Oncol 2022;12:959208. [DOI: 10.3389/fonc.2022.959208] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Xia L, Chen J, Huang M, Mei J, Lin M. The functions of long noncoding RNAs on regulation of F-box proteins in tumorigenesis and progression. Front Oncol 2022;12:963617. [DOI: 10.3389/fonc.2022.963617] [Reference Citation Analysis]
|
| 17 |
Li S, Tang M, Zen N, Liang J, Xing X, Huang D, Liu F, Zhang X. LncRNA OIP5-AS1 Knockdown Targets miR-183-5p/GLUL Axis and Inhibits Cell Proliferation, Migration and Metastasis in Nasopharyngeal Carcinoma. Front Oncol 2022;12:921929. [PMID: 35756672 DOI: 10.3389/fonc.2022.921929] [Reference Citation Analysis]
|
| 18 |
Yang X, Ma L, Fang S, Song Y, Zhu S, Jin C, Liu W, Lu Q, Zeng L, Cui S. Construction of a Competing Endogenous RNA Network and Identification of Potential Regulatory Axes in Gastric Cancer Chemoresistance. Pathology - Research and Practice 2022. [DOI: 10.1016/j.prp.2022.153904] [Reference Citation Analysis]
|
| 19 |
Li X, Li K, Li M, Lin X, Mei Y, Huang X, Yang H. Chemoresistance Transmission via Exosome-Transferred MMP14 in Pancreatic Cancer. Front Oncol 2022;12:844648. [PMID: 35223528 DOI: 10.3389/fonc.2022.844648] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 20 |
Wang Y, Wang X, Wang YX, Ma Y, Di Y. The Long-Noncoding RNA TUG1 Regulates Oxygen-Induced Retinal Neovascularization in Mice via MiR-299. Invest Ophthalmol Vis Sci 2022;63:37. [PMID: 35084431 DOI: 10.1167/iovs.63.1.37] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 21 |
Dai YC, Pan Y, Quan MM, Chen Q, Pan Y, Ruan YY, Sun JG. MicroRNA-1246 Mediates Drug Resistance and Metastasis in Breast Cancer by Targeting NFE2L3. Front Oncol 2021;11:677168. [PMID: 34926237 DOI: 10.3389/fonc.2021.677168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Ahmad A. Special Issue: Epigenetic regulation of cancer progression: Promises and progress. Semin Cancer Biol 2021:S1044-579X(21)00298-4. [PMID: 34921992 DOI: 10.1016/j.semcancer.2021.12.005] [Reference Citation Analysis]
|
| 23 |
Chi Y, Xin H, Liu Z. Exosomal lncRNA UCA1 Derived From Pancreatic Stellate Cells Promotes Gemcitabine Resistance in Pancreatic Cancer via the SOCS3/EZH2 Axis. Front Oncol 2021;11:671082. [PMID: 34868904 DOI: 10.3389/fonc.2021.671082] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 24 |
Mirzaei S, Gholami MH, Ang HL, Hashemi F, Zarrabi A, Zabolian A, Hushmandi K, Delfi M, Khan H, Ashrafizadeh M, Sethi G, Kumar AP. Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer Therapy. Cells 2021;10:3348. [PMID: 34943856 DOI: 10.3390/cells10123348] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Qiao X, Liu J, Zhu L, Song R, Zhong M, Guo Y. Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer. Int J Med Sci 2021;18:3728-37. [PMID: 34790046 DOI: 10.7150/ijms.64253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 26 |
Xiong G, Pan S, Jin J, Wang X, He R, Peng F, Li X, Wang M, Zheng J, Zhu F, Qin R. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer. Front Oncol 2021;11:765216. [PMID: 34760707 DOI: 10.3389/fonc.2021.765216] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 27 |
Smolarz B, Durczyński A, Romanowicz H, Hogendorf P. The Role of microRNA in Pancreatic Cancer. Biomedicines 2021;9:1322. [PMID: 34680441 DOI: 10.3390/biomedicines9101322] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Xu H, Chen R, Shen Q, Yang D, Peng H, Tong J, Fu Q. Overexpression of Circular RNA circ_0013587 Reverses Erlotinib Resistance in Pancreatic Cancer Cells Through Regulating the miR-1227/E-Cadherin Pathway. Front Oncol 2021;11:754146. [PMID: 34552882 DOI: 10.3389/fonc.2021.754146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 29 |
He J, Ling L, Liu Z, Ren X, Wan L, Tu C, Li Z. Functional interplay between long non-coding RNAs and the Wnt signaling cascade in osteosarcoma. Cancer Cell Int 2021;21:313. [PMID: 34130697 DOI: 10.1186/s12935-021-02013-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 30 |
Pan H, Diao H, Zhong W, Wang T, Wen P, Wu C. A Cancer Cell Cluster Marked by LincRNA MEG3 Leads Pancreatic Ductal Adenocarcinoma Metastasis. Front Oncol 2021;11:656564. [PMID: 34055623 DOI: 10.3389/fonc.2021.656564] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 31 |
Chen S, Chen C, Hu Y, Song G, Shen X. The diverse roles of circular RNAs in pancreatic cancer. Pharmacol Ther 2021;226:107869. [PMID: 33895187 DOI: 10.1016/j.pharmthera.2021.107869] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 32 |
Rong Z, Xu J, Shi S, Tan Z, Meng Q, Hua J, Liu J, Zhang B, Wang W, Yu X, Liang C. Circular RNA in pancreatic cancer: a novel avenue for the roles of diagnosis and treatment. Theranostics 2021;11:2755-69. [PMID: 33456571 DOI: 10.7150/thno.56174] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
|
